当前位置:首页 - 行情中心 - 恒瑞医药(600276) - 财务分析 - 现金流量表

恒瑞医药

(600276)

  

流通市值:3984.33亿  总市值:4145.60亿
流通股本:63.79亿   总股本:66.37亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金26,173,262,016.0415,666,363,464.516,090,507,617.7627,146,811,001.25
  收到其他与经营活动有关的现金799,560,767.34457,430,575.96211,428,920.531,322,070,742.88
  经营活动现金流入小计26,972,822,783.3816,123,794,040.476,301,936,538.2928,468,881,744.13
  购买商品、接受劳务支付的现金1,167,102,744.63910,938,758.61347,352,720.651,402,150,450.75
  支付给职工以及为职工支付的现金5,462,509,586.423,558,646,926.641,905,586,260.316,163,445,682.38
  支付的各项税费1,839,015,825.491,367,794,099.13652,139,252.42,290,150,446.16
  支付其他与经营活动有关的现金9,393,764,336.575,985,961,004.692,841,684,216.4211,190,382,126.13
  经营活动现金流出小计17,862,392,493.1111,823,340,789.075,746,762,449.7821,046,128,705.42
  经营活动产生的现金流量净额9,110,430,290.274,300,453,251.4555,174,088.517,422,753,038.71
二、投资活动产生的现金流量:
  收回投资收到的现金151,000,000150,000,000150,000,000605,485,304.68
  取得投资收益收到的现金30,047,582.8829,112,592.2218,785,809.652,505,139.45
  处置固定资产、无形资产和其他长期资产收回的现金净额7,147,978.593,719,423.421,568,511.6121,901,739
  投资活动现金流入小计188,195,561.47182,832,015.64170,354,321.21679,892,183.13
  购建固定资产、无形资产和其他长期资产支付的现金1,714,462,484.691,267,564,947.42702,031,901.521,969,197,487.86
  投资支付的现金---622,680,411.5
  投资活动现金流出小计1,714,462,484.691,267,564,947.42702,031,901.522,591,877,899.36
  投资活动产生的现金流量净额-1,526,266,923.22-1,084,732,931.78-531,677,580.31-1,911,985,716.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金10,351,937,892.2810,351,937,892.28--
  取得借款收到的现金428,335,302.78--799,909,380.08
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计10,780,273,195.0610,351,937,892.28-799,909,380.08
  偿还债务支付的现金---799,909,380.08
  分配股利、利润或偿付利息支付的现金1,274,130,192.81,274,130,192.8-1,274,788,274.05
  支付其他与筹资活动有关的现金1,415,122,611.081,038,312,699.07661,059,213.92275,801,751.83
  筹资活动现金流出小计2,689,252,803.882,312,442,891.87661,059,213.922,350,499,405.96
  筹资活动产生的现金流量净额8,091,020,391.188,039,495,000.41-661,059,213.92-1,550,590,025.88
四、汇率变动对现金及现金等价物的影响-146,577,748.5848,287,663.4729,624,153.667,400,551.34
五、现金及现金等价物净增加额15,528,606,009.6511,303,502,983.5-607,938,552.063,967,577,847.94
  加:期初现金及现金等价物余额24,239,102,117.6624,239,102,117.6624,239,102,117.6620,271,524,269.72
  期末现金及现金等价物余额39,767,708,127.3135,542,605,101.1623,631,163,565.624,239,102,117.66
补充资料:
  净利润-4,454,670,657.21-6,336,994,647.53
  资产减值准备-9,443,508.19-32,538,341.38
  固定资产和投资性房地产折旧-347,244,043.34-655,021,624.88
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-347,244,043.34-655,021,624.88
  无形资产摊销-52,108,856.42-67,263,980.25
  长期待摊费用摊销-43,231,966.88-94,789,854.75
  处置固定资产、无形资产和其他长期资产的损失--2,311,106.15--5,397,912.01
  固定资产报废损失-1,875,878.05-4,944,029.96
  公允价值变动损失--111,263,854.42--108,630,771.57
  财务费用--36,624,580.62--1,841,800.26
  投资损失-12,354,120.47--23,868,290.32
  递延所得税--21,405,272.89--23,141,400.15
  其中:递延所得税资产减少--32,699,770.72--56,618,467.73
    递延所得税负债增加-11,294,497.83-33,477,067.58
  存货的减少--173,390,260.24--135,630,816.98
  经营性应收项目的减少--691,831,578.87--375,699,363.85
  经营性应付项目的增加-280,027,724.23-671,408,644.5
  其他-126,931,999.62-209,255,274.64
  现金的期末余额-35,542,605,101.16-24,239,102,117.66
  减:现金的期初余额-24,239,102,117.66-20,271,524,269.72
  现金及现金等价物的净增加额-11,303,502,983.5-3,967,577,847.94
公告日期2025-10-282025-08-212025-04-252025-03-31
审计意见(境内)标准无保留意见
TOP↑